Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol

This publication has 16 references indexed in Scilit:

• Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition
  Fertility and Sterility, 2001
• Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol
  Human Reproduction, 2001
• Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring
  Clinical Pharmacokinetics, 2000
• Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 µg/ ethinylestradiol 15 µg and a 21-day regimen of desogestrel 150 µg/ethinylestradiol 20 µg
  The European Journal of Contraception & Reproductive Health Care, 1999
• The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 µg and ethinylestradiol 15 µg
  The European Journal of Contraception & Reproductive Health Care, 1999
• Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons
  American Journal of Obstetrics and Gynecology, 1998
• Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuation
  Contraception, 1995
• Clinical experience and pharmacological effects of an oral contraceptive containing 20μg oestrogen
  Contraception, 1992
• A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
• Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta®) and one monophasic (Neovletta®) version
  Contraception, 1983